City of Hope receives $4.9M for stem cell training program

Nancy Hanley Eriksson, Kevin Conroy receive TGen’s John S. McCain Leadership Awards

Nancy Hanley Eriksson and Kevin Conroy received John S. McCain Leadership Awards from Translational Genomics Research Institute (TGen), part of City of Hope, at the institute’s 2024 Founders Dinner, an annual gathering held April 4 in Scottsdale, AZ.

April 12, 2024

Vol.50 No.15

In Brief

Aleksandar Sekulic named director of dermatology and translational research at City of Hope Phoenix

Aleksandar Sekulic was named director of dermatology and director of translational research at City of Hope Cancer Center Phoenix. Sekulic was also hired as a professor in the Integrated Cancer Genomics Division at Translational Genomics Research Institute, also called TGen.

March 15, 2024

Vol.50 No.11

In Brief

City of Hope establishes mobile cancer prevention and screening program

City of Hope established a mobile cancer prevention and screening program.

March 01, 2024

Vol.50 No.09

Clinical Roundup

UNM completes the first allogeneic stem cell transplant in the state

Doctors at the University of New Mexico Comprehensive Cancer Center successfully treated blood cancer patients using allogeneic stem cell transplant—a first for New Mexico.

January 19, 2024

Vol.50 No.03

Clinical Roundup

City of Hope Children’s Cancer Center, Children’s Oncology Group conduct clinical trial seeking to prevent heart failure among pediatric cancer survivors

The largest clinical trial to date seeking to reduce the risk of people who have survived childhood cancer from developing heart failure found that carvedilol, a blood vessel relaxing medication, is safe for childhood cancer survivors and may improve important markers of heart injury sustained as a result of chemotherapy exposure.

January 12, 2024

Vol.50 No.02

Clinical Roundup

City of Hope preclinical study points to an immune cell that can attack cancer

According to preclinical research published in Cell, researchers with City of Hope discovered that a type of human immune cells known to be important for allergy and other immune responses—human type 2 innate lymphoid cells, or ILC2s—can also attack cancer.

January 12, 2024

Vol.50 No.02

City of Hope receives $4.9M for stem cell training program

YOU MAY BE INTERESTED IN

Nancy Hanley Eriksson, Kevin Conroy receive TGen’s John S. McCain Leadership Awards

Aleksandar Sekulic named director of dermatology and translational research at City of Hope Phoenix

City of Hope establishes mobile cancer prevention and screening program

UNM completes the first allogeneic stem cell transplant in the state

City of Hope Children’s Cancer Center, Children’s Oncology Group conduct clinical trial seeking to prevent heart failure among pediatric cancer survivors

City of Hope preclinical study points to an immune cell that can attack cancer

Renew today!

Subscriber content

Login